Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-09-29

FDA Approved: DEFEROXAMINE MESYLATE — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp's generic deferoxamine mesylate (Deferoxamine Mesylate) under an original ANDA for the treatment of iron overload due to transfusions a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Deferoxamine Mesylate (Deferoxamine)

Snippet

ORIG AP for DEFEROXAMINE MESYLATE (DEFEROXAMINE MESYLATE)